Back to Journals » Therapeutics and Clinical Risk Management » Volume 11
Perspectives
Integrating risk minimization planning throughout the clinical development and commercialization lifecycle: an opinion on how drug development could be improved
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
17,523 | Dovepress* | 15,176+ | 2,284 | 17,460 | |
PubMed Central* | 2,347 | 522 | 2,869 | ||
Totals | 17,523 | 2,806 | 20,329 | ||
*Since 26 February 2015 +Since July 2016 |
View citations on PubMed Central and Google Scholar